CDRE vs REGN · P/E 36, rev $567.6M vs P/E 14, rev $14.34B
Cadre Holdings Inc (CDRE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Cadre Holdings Inc (CDRE) is a aerospace & defense company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CDRE revenue for 2024-12-31 was $567.6M. Net income was $36.1M. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. CDRE currently screens at market cap $1.28B and trailing P/E 35.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CDRE currently screens at market cap $1.28B and trailing P/E 35.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CDRE and REGN stock pages for the full models.
Not investment advice.